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Abstract
Background: The 6-minute walk test (6MWT) is a commonly used metric for measuring change in mobility after
knee arthroplasty, however, what is considered an improvement after surgery has not been defined. The determination
of important change in an outcome assessment tool is controversial and may require more than one approach. This
study, nested within a combined randomised and observational trial, aimed to define a minimal important improvement
threshold for the 6MWT in a knee arthroplasty cohort through a triangulation of methods including patient-perceived
anchor-based thresholds and distribution-based thresholds.
Methods: Individuals with osteoarthritis performed a 6MWT pre-arthroplasty then at 10 and 26 weeks post-surgery. Each
rated their perceived improvement in mobility post-surgery on a 7-point transition scale anchored from “much better” to
“much worse”. Based on these responses the cohort was dichotomised into ‘improved’ and ‘not improved’. The
thresholds for patient-perceived improvements were then identified using two receiver operating curve methods
producing sensitivity and specificity indices. Distribution-based change thresholds were determined using two
methods utilising effect size (ES). Agreement between the anchor- and distribution-based methods was assessed
using kappa.
Results: One hundred fifty-eight from 166 participants in the randomised cohort and 222 from 243 in the
combined randomised and observational cohort were included at 10 and 26 weeks, respectively. The slightly or
more patient-perceived improvement threshold at 26 weeks (an absolute improvement of 26 m) was the only
one to demonstrate sensitivity and specificity results both better than chance. At 10- and 26-weeks, the ES based
on the mean change score divided by the baseline standard deviation (SD), was an absolute change of 24.5 and
37.9 m, respectively. The threshold based on a moderate ES (a 0.5 SD of the baseline score) was a change of 55.0
and 55.4 m at 10- and 26-weeks, respectively. The level of agreement between the 26-week anchor-based and
distribution-based minimal absolute changes was very good (k = 0.88 (95 % CI 0.81 0.95)).
Conclusion: A valid threshold of improvement for the 6MWT can only be proposed for changes identified from
baseline to 26 weeks post-surgery. The level of agreement between anchor- and distribution-based methods
indicates that a true minimal or more threshold of meaningful improvement following surgery is likely within the
ranges proposed by the triangulation of all four methods, that is, 26 to 55 m.
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Background
The 6-min walk test (6MWT) is a simple, objectively
measured, physical test that is used to evaluate improve-
ment in functional ambulation after TKA [1–8]. Simply
stated, it is a test conducted in- or out-side on level
ground where the participant is required to walk laps of
a 25 or 30 m track [9]. Participants and observers are
given standardised instructions on how to perform the
test, and the distance walked over the 6-min period in-
dependent of rest periods is recorded. The use of the
test in the TKA population arguably has content (face)
validity as improvement in mobility is regarded as a pri-
mary goal of surgery [10] and rehabilitation after TKA
surgery [11]. Further, construct validity for the test (that
is, that the test is actually a measure of functional ambu-
lation) for this population is derived from evidence that
performance in the 6MWT has been shown to be an
excellent predictor of performance in a more arduous
30-min walk test [11]. The test-retest reproducibility of
the 6MWT is also excellent in TKA recipients [12] as
well as in people with osteoarthritis awaiting arthro-
plasty [8, 13], and the test is highly responsive [8], indi-
cating the test has the ability to detect change [14].
Interestingly though, despite demonstrating sound
clinimetric properties and despite its common use both
in the clinic [13, 15, 16] and in clinical trials [1–8], there
are no published data on what may be minimal, moder-
ate or large improvements in this test as perceived by
the patient following TKA. Knowledge of what are consid-
ered small or large changes by the patient may be relevant
for determining whether or not a change in therapy is in-
dicated (at the level of the individual) as well as for sample
size calculations for clinical trials [17–19]. Data exist on
what minimal important differences (MID) are detectable
for this test in this population using distribution-based
methods based on observed scores [8, 20]. These methods
express change in terms of a standardised metric such as
0.5 of a standard deviation (0.5SD) or the standardised
error of measurement (SEM) [14, 21]. The SEM has been
reported to be 28.5 m in people with knee osteoarthritis
awaiting TKA [13]. Similar values have been reported six
(25.5 m [12]) and eight weeks (26 m, [8]) post-TKA. Miz-
ner et al [20] report the ES to be 0.66 (81 m) 1 year after
surgery. However, distributional methods are criticised for
ignoring the clinical importance of the magnitude of the
change, for not including a measure of change as
perceived by the patient, and for not necessarily being a
‘minimal’ change [14, 20]. An alternative method for
determining MIDs, which does incorporate the views of
the patient, is an anchor-based method. Anchor-based
methods use an external reference (or anchor) by which
to categorise respondents [14, 21]. Often these are
patient-based and require the patient to qualify their glo-
bal perception of change on a transition scale. Criticisms
of anchor-based methods, however, are that they are
prone to recall bias – that is, faulty recollection by the re-
spondent [14, 21, 22] - and response-shift – a change in
the respondent’s understanding of the construct being ex-
amined over time [22].
In light of the limitations of the methods to determine
minimal or even moderate or large change thresholds,
the use of multiple methods and triangulation of meth-
odologies have been recommended [14, 21]. This study
aimed, therefore, to define an improvement threshold
for the 6MWT in a TKA cohort through a triangulation
of methods using patient-perceived anchor-based im-
provement thresholds as well as distribution-based im-
provement thresholds.
Methods
Study design and setting
This study was nested within a multicentre, two-armed
randomised controlled trial (HIHO) with a third non-
randomised, observational arm [2] (http://clinicaltrials.-
gov ref NCT01583153). The controlled trial was de-
signed to test the superiority of 10 days of inpatient
rehabilitation together with a monitored home program
on measured mobility over a monitored home program
(usual care) alone following TKA. Those in the observa-
tional cohort received the same home program after
their TKA. All participants provided informed, written
consent and the study was approved by the human re-
search ethics committees of the institutions involved.
The protocol for the clinical trial is described in detail
elsewhere [2]; a summary of the study procedures is
provided herein.
Participant screening and recruitment
Potential participants were screened by research personnel
during their pre-admission visit approximately 4 weeks
prior to surgery. Adults presenting to either of two metro-
politan hospitals for a primary, unilateral TKA, with a pri-
mary diagnosis of knee osteoarthritis were eligible to
participate in the RCT. People who were eligible, but
declined to be included in the randomised arms of the
study, were invited to participate in the observational arm
whereby they received usual care. Socio-demographic and
anthropometric data were obtained at this time. People
who were unable to comprehend the study protocol, un-
able to perform exercises in an unsupervised environment,
unable to attend one of three physiotherapy departments
involved in the study, or who had a predisposition to be
discharged to a rehabilitation facility (for example, they
lived alone), were excluded from the study.
Outcomes and testing procedures
After consent was obtained, each participant completed
patient-reported surveys relevant to the larger study and
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completed a 6MWT on an outside 30 m straight track
according to recommended testing procedures [9]. A
practise 6MWT was not undertaken as all patients pre-
senting for TKA at the study hospitals were required
to perform the test at several time points whilst await-
ing surgery as part of a waitlist management program
[13, 15, 16]. At 10 weeks (randomised participants
only) and 26 weeks (all participants) post-surgery, the
6MWT was repeated. Prior to testing, participants
were asked to rate their perceived improvement in
their mobility three ways; at 10 weeks, anchored to
pre-surgery, then at 26 weeks, anchored to both pre-
surgery and 10 weeks.
For rating patient global impression of improvement,
we used an anchor-based method commonly recom-
mended for determining the minimal important im-
provement [18, 23–25]. Participants were asked to rate
their perceived improvement in mobility on a 7-point
Likert scale. Each denoted whether they were ‘much
worse’, ‘moderately worse’, ‘slightly worse’, ‘no change/
same’, ‘slightly better’, ‘moderately better’, ‘much better’,
compared to how they were prior to surgery. The global
style of questioning used – ‘How does your walking
compare to before surgery?’– was consistent with previ-
ous studies which have identified minimum thresholds
for improvement for the 6MWT in other clinical popu-
lations [18, 19, 24].
Preliminary analyses
Prior to analyses of the improvement thresholds, growth
curve analyses were conducted to determine whether
there were differences in the magnitude (model 1) and
rate of change (model 2) in the 6MWT over the follow-
up periods [26, 27]. These analyses allowed us to
robustly deal with the change in sample size across
different time points, but also indicated whether any
improvement thresholds identified could apply across all
time periods. The latter was important as MIDs are
thought to be time-specific [14, 28, 29]. A third model
was fitted to determine the influence of readily measur-
able patient variables on baseline 6MWT distance and/
or the magnitude and rate of change over time (body
mass index (BMI), age, gender, comorbidity count, base-
line disease severity). This analysis was necessary as it
would identify whether an improvement threshold could
apply regardless of participant characteristics. For the
purposes of this predictor model, rehabilitation group
allocation was ignored as it was found to not signifi-
cantly interact with baseline 6MWT or improvement
in distance over time. To ensure best fit of the data,
all models were fitted using an unstructured covari-
ance structure, which requires no assumption in error
structure [26].
Analyses of thresholds
Anchor- and distribution-based approaches were utilised
for determining meaningfulness of the improvement
thresholds.
For the anchor-based method, identification of the
thresholds and determining their acceptability were per-
formed over three stages. Firstly, correlation between the
absolute change scores from baseline to each follow-up
period and the Likert scale was assessed using Spear-
man’s rank correlation. This was repeated for the relative
change scores, where 6MWT distance was expressed as
a percentage of baseline. While the optimal correlation
coefficient for a typical MID analysis is conventionally
regarded as >0.3 [14], due to the exploratory nature of
this study, we chose to investigate the improvement
thresholds that had any statistically significant (p <0.05)
correlation.
Secondly, the improvement thresholds were investigated
by dichotomising all participants into “improved” and
“not-improved” groups. For the minimal group, the dichot-
omy was set with those reporting slightly improved or
more (that is they reported slight, moderate or much bet-
ter improvement) as the improved group and those report-
ing no change or worse as the not-improved group. The
moderate group split occurred at the moderately better or
more level, and the much better difference group only
included those reporting they were much better. A
priori, we had planned to identify the slight, moderate
or much better thresholds in non-overlapping (inde-
pendent) groups, however, too few people reported to
be slightly better or even moderately better. Any con-
clusive analysis using these original categorisations was
precluded, therefore, because such a small sample in
the ‘slightly better’ group threatened the precision of
the estimates obtained [30].
Thirdly, the 6MWT data, now dichotomised into those
who had reported improvement or not, were plotted on
a receiver operating characteristic (ROC) curve, with the
improved group as the reference group on all occasions.
This was done for all three improvement threshold
groups. The area under the curve (AUC) and 95 % confi-
dence intervals (CI) were calculated for each ROC curve
in order to provide insight into the discriminatory power
of the transition question. These were compared using
DeLong’s statistic (D) to determine if using the slight,
moderate or much better change was a more appropriate
method for determining what would be useful clinically
or scientifically. An AUC of 75 % or more has previously
been proposed to be clinically useful [31]. The threshold
of difference was then set using two methods: the first,
the top left hand corner of the graph that results in the
optimal combination of sensitivity and specificity, known
as Youden’s method [32]; the second, the 80 % specificity
method [33], selects the threshold that has a minimum
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of 80 % specificity while obtaining the highest possible
sensitivity. Confidences intervals (CIs) for the sensitivity
and specificity of each threshold were calculated using
500 bootstrap samples. Values greater than 50 indicated
that the thresholds were better at identifying individuals
who would (sensitivity) and would not (specificity) im-
prove to a patient-perceived amount. ROC curves were
calculated for the change in 6MWT both in absolute
terms and as a percentage of the patient’s baseline value.
The distribution-based approach utilised the ES. There
are two methods to this approach. The first examines
the mean differences between pre- and post-surgical
6MWT distances and divides them by the standard devi-
ation (SD) of the pre-surgery distance [34]. The second
method is to determine 50 % of the SD of the baseline
score, which correlates to a moderate effect [35]. This is
a commonly used method to obtain a MID [36] and is
based on a systematic review of 29 investigations across
several disease conditions, which reported that the ES
converged on 0.5 SD [35]. These methods were applied
to both absolute and relative scores at 10- and 26-weeks
post TKA. To examine the concordance in classifica-
tions between the anchor- and distribution-based MID
thresholds, we used the kappa index of agreement [37].
To obtain 95 % confidence intervals for the kappas, we
used 500 bootstrap samples.
Results
Of the 243 participants included in the larger study,
166 and 77 belonged to the RCT and observational
arms, respectively; 158 were available at the 10-week
assessment (RCT participants only) and 222 were avail-
able at the 26-week assessment (RCT and observational
combined). Table 1 summarises the characteristics of
the cohort according to their study grouping (RCT or
observational).
Growth curve analyses
The unadjusted mean preoperative distance was 322.4
(sd 110.6) m (Table 1) and the unadjusted distances
achieved at 10 and 26 weeks were 375.5 (108.26) and
386.7 (113.2) m, respectively. The rates of improvement
in the 6MWT changed significantly over time (refer to
Appendix 1: Table 4). From 0 to 10 weeks, the adjusted
mean increase in distance was 5.3 m per week for an
average male. This rate slowed to a rate of 0.8 m im-
provement per week from weeks 10 to 26. While age
and gender influenced preoperative 6MWT distance,
they had no effect on the magnitude or rate of change.
These results indicated that any significant thresholds
that were identified would apply regardless of differences
in the participant characteristics included in the model,
but owing to the effect of time on improvement, any
proposed threshold would be time-specific.
Anchor-based estimation of improvement thresholds
Correlation of the transition scale with measured change
While the global transition scale was significantly corre-
lated with the absolute and relative changes in 6MWT
distance from baseline to 10- and 26-weeks, the correl-
ation coefficients were small (Table 2). Further, there
was no correlation between the changes in 6MWT from
10-weeks to 26-weeks and the transition scale. As such,
the determination of improvement thresholds in the
period between the 10- and 26-week follow-ups was ex-
cluded from further analysis.
Categorisation of improved versus not improved
participants
At the 10-week assessment, there were 140 (89 %), 128
(81 %) and 85 (54 %) people included in the slightly or
more, moderate or more and much better improvement
categories, respectively. At 26 weeks, there were 188
(85 %), 179 (81 %) and 143 (64 %) in each of the thresh-
old categories. Figure 1 indicates the mean deterioration
or improvement in 6MWT distance observed between
categories is not linear; in other words, there is not a
graduated increase or decrease from category to cat-
egory. Through reference to the wide range of maximum
negative and positive change observed within each cat-
egory (Table 3), it can be seen that some people in the
‘slightly improved or more’ category (that is, they re-
ported they were slightly better or more), demonstrated
greater improvement or deterioration than people in the
‘much better’ category (that is, those who reported they
were much better).










Age, yrs, mean (sd) 67.0 (8.3) 66.7 (8.7) 66.9 (8.4)
Gender, female, n (%) 112 (68) 35 (45) 147 (61)
Body mass index, mean (sd) 34.7 (7.0) 33.0 (7.2) 34.2 (7.1)
Baseline 6-min walk test,
mean (sd)
319.1 (109.1) 329.5 (114.0) 322.4 (110.6)
Baseline Oxford Knee Score 17.0 (7.1) 17.6 (7.7) 17.2 (7.3)
Comorbidity, yes, n (%) 127 (77) 53 (69) 180 (75)
Cardiovascular 116 (70) 47 (61) 163 (67)
Gastrointestinal 53 (32) 11 (14) 64 (26)
Other lower limb
or back
43 (26) 21 (27) 64 (26)
Diabetes Mellitus 38 (23) 18 (23) 56 (23)
Respiratory 21 (13) 10 (13) 31 (13)
Key: Five most common comorbidities shown
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Area under the curve, specificity and sensitivity analyses
The AUCs indicated that the improvement thresholds
were not highly discriminatory with respect to measured
changes in the 6MWT (60–75 %) regardless of whether
relative or absolute change was used (Table 3). Further,
there was no difference in discriminatory power between
slight or more, moderate or more and much better defini-
tions of improvement (Fig. 2). The Youden’s and 80 % spe-
cificity method resulted in different thresholds of slight or
more, moderate or more and much better important
change. Slight improvement or more at 26-weeks was the
only set of thresholds where the specificity and sensitivity
were both greater than 50 % for absolute and relative
change in both the Youden and 80 % specificity methods.
That is, they were the only thresholds considered to have
a sensitivity and specificity which were uniformly better
than chance, regardless of the analysis method. The abso-
lute values indicated that a “slight improvement or more”
ranged from 26 to 64.5 m improvement in distance, or a
relative increase between 11.3 and 18.3 %. For the
remaining 10- and 26-week thresholds either the sensitiv-
ity or specificity were poor suggesting that they are sub-
optimal for identifying clinically useful improvement in a
cohort regardless of the improvement category used
(Table 3).
Distribution-based estimation of improvement thresholds
At 10-weeks, the ES based on the mean change score
(52 m) divided by the baseline SD (110 m) was 0.5. This
equivocated to an improvement of 24.5 m or 12.7 %
Table 2 Spearman’s correlation coefficient between the transition scale, and absolute and relative change in 6MWT distance
Change in 6MWT Rating on transition scale
Baseline to 10-weeks Baseline to 26-weeks 10-weeks to 26-weeks
Absolute Baseline to 10-weeks 0.297 (p < 0.001) NA NA
n = 156
Relative Baseline to 10-weeks 0.259 (p < 0.001) NA NA
n = 156
Absolute Baseline to 26-weeks NA 0.259 (p < 0.001) NA
n = 211
Relative Baseline to 26-weeks NA 0.239 (p < 0.001) NA
n = 211
Absolute10-weeks to 26-weeks NA NA 0.03 (p = 0.73)
n = 139
Relative 10-weeks to 26-weeks NA NA 0.054 (p = 0.526)
n = 139
NA not applicable
Fig. 1 Mean change in 6MWT distance for each category of the transition scale for baseline to 10-weeks post op (foreground) and baseline to
26-weeks (distance). Sample size varied greatly for each category. At 10-weeks, much better n = 85, moderately better n = 43, slightly better
n = 12, no change n = 6, slightly worse n = 2, moderately worse n = 7 and much worse n = 2. At 26-weeks, much better n = 143, moderately
better n = 36, slightly better n = 9, no change n = 9, slightly worse n = 4, moderately worse n = 3, much worse n = 7
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Table 3 Area under the curve for ROC curves as well as slight or more, moderate or more and much better important difference for both the absolute and relative changes for
the 6MWT
Important change Max negative and positive
changes in distancea













Slight or more (n = 140) −148.0 m to 290.0 m 70.1 % (55.58, 84.7) 11.5 m 70.2 (62.41, 78.39) 66.7 (40, 86.67) 53.0 m 48.9 (41.13, 57.45) 80.0 (60, 100)
Moderate or more (n = 128) −148.0 m to 290.0 m 72.3 % (51.15, 83.35) 11.5 m 74.4 (66.67, 82.95) 70.4 (51.85, 85.19) 53.0 m 51.9 (42.64, 60.47) 81.4 (66.67, 92.59)
Much better (n = 85) −148.0 m to 252.0 m 62.8 % (53.85, 71.78) 11.5 m 79.1 (70.93, 87.21) 48.6 (36.39, 60) 106.5 m 29.1 (19.16, 38.37) 80.0 (71.43, 88.57)
10 weeks Relative
Slight or more (n = 140) −92.6 to 486.0 % 67.3 % (51.21, 83.44) 5.1 % 66.7 (58.16, 74.13) 66.7 (40, 86.67) 15.1 % 49.7 (40.43, 58.16) 80.0 (60, 100)
Moderate or more (n = 128) −92.6 to 486.0 % 70.7 % (59.05, 82.32) 5.1 % 70.5 (62.02, 78.29) 70.4 (51.85, 85.19) 15.5 % 48.8 (40.31, 56.59) 81.5 (66.67, 94.54)
Much better (n = 85) −92.6 to 486.0 % 60.7 % (51.53, 69.9) 5.7 % 54.3 (44.29, 65.71) 70.5 (63.95, 83.17) 49.1 % 23.3 (15.12, 32.56) 80.0 (70.68, 88.57)
26 weeks Absolute
Slight or more (n = 188) −242.3 m to 370.0 m 72.4 % (62.05, 82.7) 26 m 72.9 (66.21, 79.26) 65.2 (45.54, 82.61) 64.5 m 50.0 (43.09, 56.91) 82.6 (67.28, 95.65)
Moderate or more (n = 179) −242.3 m to 370.0 m 70.6 % (60.33, 80.94) 6.5 m 81.6 (75.98, 87.15) 56.3 (38.98, 71.88) 71.0 m 48.0 (41.05, 55.31) 81.3 (67.28, 95.65)
Much better (n = 143) −194.0 m to 370.0 m 64.7 % (56.59, 72.77) 8.5 m 84.4 (78.01, 90.07) 41.4 (31.43, 54.29) 110.5 m 35.5 (27.66, 43.63) 81.4 (72.86, 90)
26 weeks Relative
Slight or more (n = 188) −93 to 515.2 % 71.7 % (60.64, 82.79) 11.3 % 65.4 (58.51, 72.09) 73.9 (56.52, 89.24) 18.3 % 52.1 (45.74, 59.04) 82.6 (67.28, 95.65)
Moderate or more (n = 179) −93.2 to 515.2 % 69.6 % (58.74, 80.4) 1.5 % 82.1 (76.54, 87.71) 56.3 (37.5, 71.88) 27.9 % 40.78 (33.78, 48.6) 81.3 (65.62, 93.75)
Much better (n = 143) −91.3 to 515.2 % 63.4 % (55.07, 71.78) 1.54 % 85.1 (79.06, 90.78) 41.4 (30, 52.86) 61.0 % 21.3 (14.18, 27.66) 84.3 (74.29, 84.29)
aChange in distance from pre-operative 6MWT. Negative integers and percentages <100 % indicate 6MWT is less than preoperative values. Positive integers and percentages >100 % indicate farther distance














being considered an important change. At 26-weeks this
method (64.8 m/110.8) resulted in an ES of 0.6 and pro-
posed threshold of 37.9 m or 19.6 % change. The distri-
bution MID based on 0.5SD of baseline scores was an
improvement of 55.0 m or 14.6 % of baseline scores at
10-weeks post-surgery and 55.4 m or 14.3 % at 26-weeks
post-surgery.
Agreement between anchor- and distribution-based
methods
The kappa level of agreement between the 26-week
anchor- and distribution-based minimal change
ranged from moderate to strong for absolute change.
Agreement between the 80 % specificity ROC method
and ES distribution approach exhibited the lowest
agreement (k = 0.67 (95 % CI 0.57, 0.76)) and the high-
est agreement occurred between the Youden ROC
method and ES distribution approach (k = 0.88 (0.81,
0.95)). Similarly, when thresholds of relative change
were examined, agreement between anchor- and
distribution-based approaches ranged from moderate
to almost perfect. The lowest agreement was between
the Youden ROC method and ES distribution ap-
proach (k = 0.69 (0.6, 0.78)) and highest was between
the Youden ROC method and 0.5SD distribution ap-
proach (k = 0.91 (0.85, 0.96)).
Discussion
To our knowledge, this is the first study to attempt to
explore the possibility that patient-perceived improve-
ment thresholds exist for the 6MWT in a TKA cohort.
Specifically, we have explored improvement and change
thresholds for the 6MWT, using multiple analytical
approaches and at two clinically relevant time periods:
10-weeks post-surgery, a time when formalised re-
habilitation is typically concluding, and at 26 weeks
post-surgery, a time when recovery is typically plateau-
ing [3, 6, 7].
Further, our cohort characteristics signify an elderly
population of people with end-stage osteoarthritis with
significant impairment as indicated by the very low
mean baseline Oxford scores (mean 17 from a maximum
of 48), and the poor baseline walk tests which are well
below the typical distances (582 m) measured in healthy
Fig. 2 ROC curves depicting Absolute (top row) and Relative (bottom row) improvement in 6MWT distance (black line) and 95 % CI of specificity
(grey shading) at 26-weeks post-operative. Panels a and d depict the slight or more important difference b and e depict moderate or more
important and c and f depict much better important difference. DeLong’s test compares AUC of graph to that of the minimal important difference
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70-year olds [11]. These characteristics, including their
comorbidities, typify TKA populations captured locally
[3, 4] as well as those captured internationally [6–8].
Our observations, therefore, should be both useful to cli-
nicians involved in the rehabilitation of TKA recipients
and be broadly generalizable.
By using both anchor-based and distribution-based
approaches and then assessing the level of agreement
between the thresholds obtained by each approach,
we have identified a slight or more improvement
threshold at 26-weeks post-surgery for the 6MWT in
a TKA cohort. Based on triangulation of all four
methods (two ROC approaches utilising patient-
perceived change, and two distributional approaches),
and considering only the anchor-based and distribu-
tional thresholds with good agreement, it appears that
the true threshold of a minimally important change is
between 26 m and 55 m. Interestingly, and probably
importantly, the threshold range we have identified
appears consistent with patient-perceived change
thresholds for the 6MWT determined in other patient
populations using anchor-based methodologies. For
patients with heart disease, it has been estimated to
be 25 m [18]. In older adults with mobility impair-
ments, a small meaningful change has been found to
be 19 to 22 m and a more substantial change has
been found to be 47 to 49 m [19]. An MID of 25 m
was identified for patients with COPD [24].
In determining the contribution this study makes to
this area, our study has strengths and limitations. The
strengths of our study lie in the comparatively large
sample size, its prospective, longitudinal design, and
the inclusion of participants from both arms of our
combined randomised and observational study - the
latter enhancing the generalisability of our findings. We
also used multiple methods to establish the one thresh-
old we did identify whilst considering the potential con-
founders of time and patient characteristics. Further,
our study describes an improvement threshold in the
6MWT post-TKA that can be applied at the level of the
individual. The use of the ROC curve approach allows
the identification of important patient level-change,
whereas approaches only applying distribution-based
methodologies necessarily confine their changes to
group-level change only [16, 36].
That we identified a range over which small improve-
ment may be considered to have occurred as opposed to
a single ‘cut-off ’ figure is unusual when determining
MIDs, but may be considered quite useful. This is
because it allows flexibility in how we perceive improve-
ment for the individual and within groups, acknowledg-
ing that there are multiple non-medical variables or life
events that may influence a person’s recovery post-TKA.
Thus, there is not likely to be a single MID threshold
that is universally representative. We also note that it is
likely that future researchers in this area (arthroplasty,
6MWT and MID) will confront the same issue we faced
with too few people reporting slight improvement, thus
necessitating slight or more improvement threshold-
type categorisations. This is because for many if not all
TKA cohorts, very large improvements in various out-
comes, including mobility, are typically seen [4, 8, 20].
Another difficult challenge in this area is applying a
global question which captures all elements of im-
provement. Whilst we applied a global anchor which
would allow us to compare our findings to others ex-
ploring change thresholds for the 6MWT, it may not
have captured all the elements of improvement (or de-
terioration) in walking ability as perceived by the pa-
tient (and this would be the case for previous studies
applying a similar anchor). Consequently, a lack of
ability of our global question to capture all elements of
improvement may have contributed to the weak corre-
lations observed between the transition responses and
measured improvements in walk distance. The 6MWT
is essentially a test of gait speed; improvement may
have occurred in other dimensions such as movement
quality and, thus, not have been detected by the
6MWT or, for that matter, any other of the time-based
mobility tests such as the timed up-and-go or 15 m
walk test commonly used to test mobility after TKA
[38]. It would appear a more specific question around
improvement in speed per se or the use of a mobility
test that is not time-based may be required to secure a
greater correlation between measured change and per-
ceived change, and, thus, achieve greater precision in a
patient-perceived improvement threshold. Of course
recall bias or response shift may also have contributed
to the weak correlations observed, and this is not likely
to be helped by a different global question. It should
also be acknowledged that it is known that there is
even poor concurrent validity between performance
measures and what patients perceive they can do after
TKA [20], thus, a more precise patient-perceived an-
chor or improvement for the 6MWT may never be
found.
Conclusions
In conclusion, though the 6MWT is commonly used
to evaluate recovery after TKA, uncertainty exists as
to what is considered a minimal or even large im-
provement as perceived by the patient. Using multiple
methods and subsequent triangulation of these
methods, the likely minimum threshold about which
patient-perceived improvement from pre-surgical sta-
tus can be considered to have occurred is between 26
and 55 m at approximately six months after surgery.
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